Evidence map›Paper›PMID 33402956›Full record

ArticleAfrican health sciences2020

An evaluation of six-year

Nevin Ince, Dilek Yekenkurul, Ayşe Danış, Emel Çalışkan, İdris Akkaş

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in African health sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Intra-Abdominal Abscess and Bacteremia Due toInfection and drug resistance · 2023
    Article
  8. Article
  9. Article
  10. Twenty years ofAfrican health sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nevin InceDepartment of Infectious Diseases and Clinical Microbiology, Duzce University Faculty of Medicine, Duzce, Turkey.
Dilek YekenkurulDepartment of Infectious Diseases and Clinical Microbiology, Duzce University Faculty of Medicine, Duzce, Turkey.
Ayşe DanışDuzce University Research and Application Hospital, Infection Control Committee Nurse Duzce, Turkey.
Emel ÇalışkanDepartment of Clinical Microbiology, Duzce University Faculty of Medicine, Duzce, Turkey.
İdris AkkaşDepartment of Infectious Diseases, Oltu State Hospital, Ministry of Health, Erzurum, Turkey.
Düzce Üniversitesi · TRErzurum Regional Training and Research Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectiveThe aim of this study was to evaluate the epidemiology of

methodsThe incidence, clinical characteristics, antimicrobial susceptibility and outcomes of nosocomial

resultsDuring the study period, 67 samples obtained from 61 patients were identified. Pneumonias (82%) were the most common HAIs, followed by bloodstream infections (10.5%), urinary tract infections (3%), skin and soft tissue infections (3%) and surgical site infection (1.5%). Admission to intensive care, hospitalization exceeding 30 days, and previous use of broad-spectrum antibiotics constituted risk factors. Resistance to cotrimoxazole (6%) was lower than that to levofloxacin (18%).

conclusionThe most important risk factors for

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionAnti-Bacterial AgentsBacteremiaCross InfectionFemaleGram-Negative Bacterial InfectionsHospitalizationHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAnti-Bacterial Agentsepidemiologyhospital-acquired infectionsrisk factorsStenotrophomonas maltophilia

Identifiers

PMID33402956
PMCPMC7751516
OpenAlexW3091873531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.